Position in VRTX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$521,566
-$136,633 QoQ
Shares Held
1,050
-28.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,062
of 1,735 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Abel Hall, LLC holds $15,603,659 across 68 Biotechnology names. VRTX ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,394 | $1,010,188 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,389 | $745,823 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
13,570 | $745,535 | |
| 4 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
8,329 | $678,896 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
4,681 | $536,770 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
4,286 | $525,377 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,050 | $521,566 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
6,619 | $492,983 |
All Filings in VRTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $521,566 | 1,050 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $658,199 | 1,474 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $616,569 | 1,360 | Shares | Sole | 2026-02-17 | |
| 2025-06-30 | $231,949 | 521 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $275,377 | 568 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $210,209 | 522 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $224,168 | 482 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $220,298 | 470 | Shares | Sole | 2024-07-25 | |
| No filing history on record for this holder in this stock. | ||||||